1-7 of 7
Juliane Gust
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CARdinal signs of variant ICANS

Juliane Gust, Nirali N. Shah
Journal: Blood
Blood (2024) 144 (13): 1352–1354.
https://doi.org/10.1182/blood.2024025664
Published: 2024
Journal Articles

BCMA-CAR T-cell treatment–associated parkinsonism

Juliane Gust
Journal: Blood
Blood (2023) 142 (14): 1181–1183.
https://doi.org/10.1182/blood.2023021860
Published: 2023
Journal Articles

How I treat unique and difficult-to-manage cases of CAR T-cell therapy–associated neurotoxicity

Clinical Trials & Observations
Bianca D. Santomasso, Juliane Gust, Fabiana Perna
Journal: Blood
Blood (2023) 141 (20): 2443–2451.
https://doi.org/10.1182/blood.2022017604
Published: 2023
Journal Articles

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy

Rebecca A. Gardner, Francesco Ceppi, Julie Rivers, Colleen Annesley, Corinne Summers, Agne Taraseviciute, Juliane Gust, Kasey J. Leger, Katherine Tarlock, Todd M. Cooper, Olivia C. Finney, Hannah Brakke, Daniel H. Li, Julie R. Park, Michael C. Jensen
Journal: Blood
Blood (2019) 134 (24): 2149–2158.
https://doi.org/10.1182/blood.2019001463
Published: 2019
Includes: Supplemental data
Journal Articles

Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after CD19 CAR-T Cell Immunotherapy

Cameron J. Turtle, MBBS, PhD, Kevin A. Hay, MD FRCPC, MSc, Laila-Aicha Hanafi, PhD, Juliane Gust, MDPhD, W. Conrad Liles, MDPhD, José A. López, MD, Junmei Chen, PhD, Dominic W. Chung, PhD, Mark M Wurfel, MDPhD, Susanna Harju-Baker, PhD, Hasan Ozpolat, MD, Daniel Li, PhD, David Myerson, MDPhD, Luis F. Gonzalez-Cuyar, MD, Cecilia Yeung, MD, Kathleen R. Fink, MD, Stanley R. Riddell, MD, David G. Maloney, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 805.
https://doi.org/10.1182/blood.V130.Suppl_1.805.805
Published: 2017
Journal Articles

Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy

Clinical Trials & Observations
Kevin A. Hay, Laïla-Aïcha Hanafi, Daniel Li, Juliane Gust, W. Conrad Liles, Mark M. Wurfel, José A. López, Junmei Chen, Dominic Chung, Susanna Harju-Baker, Sindhu Cherian, Xueyan Chen, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle
Journal: Blood
Blood (2017) 130 (21): 2295–2306.
https://doi.org/10.1182/blood-2017-06-793141
Published: 2017
Includes: Supplemental data
Journal Articles

Decreased Rates of Severe CRS Seen with Early Intervention Strategies for CD19 CAR-T Cell Toxicity Management

Rebecca Gardner, MD, Kasey J Leger, MD MSc, Colleen E. Annesley, MD, Corinne Summers, MD, Julie Rivers, MD, Juliane Gust, MD, Katherine Tarlock, MD, Todd M Cooper, DO, Navin R. Pinto, MD, Olivia Finney, PhD, Hannah Smithers, MS, Assaf Oron, PhD, Daniel Li, PhD, Julie R Park, MD, Michael C Jensen, MD
Journal: Blood
Blood (2016) 128 (22): 586.
https://doi.org/10.1182/blood.V128.22.586.586
Published: 2016